Intravenous NPA for the treatment of infarcting myocardium early. InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction
Open Access
- 15 December 2000
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 21 (24) , 2005-2013
- https://doi.org/10.1053/euhj.2000.2498
Abstract
Aims To compare the efficacy and safety of lanoteplase, a single-bolus thrombolytic drug derived from alteplase tissue plasminogen activator, with thKeywords
This publication has 0 references indexed in Scilit: